Clinical Trials Directory

Trials / Completed

CompletedNCT03244722

Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
147 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Our hypothesis is that aggressive preconception weight loss in obese women will improve the metabolic health of the mother and the intrauterine environment. An optimized developmental environment will normalize fetal growth and improve clinical fetal and infant outcomes, and theoretically reduce future susceptibility to obesity and cardiometabolic disease.

Detailed description

Further, our hypothesis is that the metabolic profiles in the mother and infant cord blood and epigenetic profiles in cord blood leukocytes will be improved in the very-low energy diet (VLED) group compared to standard practice nutrition counseling and support (SOC) group and approach the profiles found in normal weight (LEAN) individuals. We will relate these changes to the changes in the offspring clinical profiles. With these data in hand, we will develop a model to understand the potential molecular markers associated with offspring size and adiposity at birth, risk factors for later onset non-communicable diseases. We will use these insights to define, adopt and implement future interventions that mitigate the downstream risk of adiposity and cardiometabolic diseases.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVery-low energy Diet (VLED)Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline
OTHERStandard of care (SOC)Standard consultation with registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss in obese women. Standard of care for normal weight women

Timeline

Start date
2018-04-10
Primary completion
2025-06-14
Completion
2025-08-29
First posted
2017-08-09
Last updated
2025-09-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03244722. Inclusion in this directory is not an endorsement.